search buttonmobile navigation expand button

Need Assistance?

Back to Search Results


BZ-007: Use of the BioZorb implant to delineate the tumor excision site following lumpectomy
This study is being done in order to collect information regarding the BioZorb tissue marker.  It is a registry of data that may be used to publish information regarding the clinical use of this FDA cleared, 3-dimensional device placed by the surgeon at the time that tissue is removed from the breast.  This particular registry will include patients undergoing breast surgery and it will collect data about its use during and after surgery.  
Trial Information
Principal Investigator: Dr. Kiran Devisetty, MD

Contact: Study Coordinator
Phone (Main): 810-342-3784

IRB Number: 2015-00077

More Information: